Thyroid diseases and their impact on the course of pregnancy

Bakhareva I.V.

doi:https://doi.org/

Close metadata

Recommended articles:

The practice of using medical abortion in the world. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):19-24

Acute kidney injury during pregnancy with favorable obstetric and nephrological outcome. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):65-70

Asplenia — a new cause of thrombosis in pregnant women?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):71-76

Modern aspects of gestational diabetes mellitus: definition, risk factors. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):35-41

Clinical case of primary hyperaldosteronism detected during pregnancy: differential diagnosis, neonatal prognosis. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):98-104

Hormonal contraception methods and multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30

Reproductive health of women with hepatitis C (literature review and own data). Russian Journal of Human Reproduction. 2025;(1):12-20

Diagnostics of hypertensive disorders in cardio-obstetrics: current state-of-affairs. Russian Journal of Human Reproduction. 2025;(1):63-77

Prevention of recurrent laryngeal nerve injury in thyroid surgery: a systematic review and meta-analysis. Pirogov Russian Journal of Surgery. 2025;(3):140-148

Epidemiological monitoring of morbidity in pregnant women in the Russian Federation: trends and medical and organizational prerequisites for adjusting prevention programs at the population level. Russian Journal of Human Reproduction. 2025;(2):7-16

Abstract:

This paper outlines current views on the etiology, pathogenesis, and clinical manifestations of thyroid diseases in reproductive-aged women and their impact on the course of pregnancy. Particular attention is given to thyroid autoimmune disorders, higher miscarriage rates in particular, in women with autoimmune disorders, to the possible progression of hypothyroidism during pregnancy, and to the development of postpartum thyroiditis. The author also describes the impact of thyroid disease on fetal development and underlines the need to screen and monitor thyroid function, to treat and prevent iodine-deficiency states, by using the preparations of iodine in combination with its synergists that are optimally combined as part of vitamin/mineral supplementation.

Keywords:

thyroid

pregnancy

autoimmune disorders

iodine prevention

postpartum thyroiditis

vitamin/mineral supplementation

Authors:

Bakhareva I.V.

Kafedra akusherstva i ginekologii lechebnogo fakul'teta Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta im. N.I. Pirogova

Close metadata

References:

Balabolkin M.I., Klebanova E.M., Kleminskaya V.M. Differentsial'naya diagnostika i lechenie endokrinnykh zabolevanii. M: Meditsina 2002; 752.
Burumkulova F.F., Gerasimov G.A. Zabolevaniya shchitovidnoi zhelezy i beremennost'. Probl endokrinol 1998; 2: 27-32.
Gerasimov G.A., Sviridenko N.Yu. Ioddefitsitnye zabolevaniya. Diagnostika, metody profilaktiki i lecheniya. Ter arkh 1997; 10: 1-3.
Gromova O.A., Torshin I.Yu., Kosheleva N.G. Molekulyarnye sinergisty ioda: novye podkhody k effektivnoi profilaktike i terapii ioddefitsitnykh zabolevanii u beremennykh. RMZh 2011; 19: 2: 1-9.
Dedov I.I., Mel'nichenko G.A., Andreeva E.N., Arapova S.D. Ratsional'naya farmakoterapiya zabolevanii endokrinnoi sistemy i narusheniya obmena veshchestv. M: Literra 2006; 1114.
Dedov I.I., Mel'nichenko G.A., Troshina E.A., Platonova N.M., Abdulkabirova F.M., Shatnyuk L.N., Apanasenko B.P. Defitsit ioda - ugroza zdorov'yu i razvitiyu detei Rossii: Puti resheniya problemy (natsional'nyi doklad). M: NTTs 2006; 1-32.
Mel'nichenko G.A., Fadeev V.V., Dedov I.I. Zabolevaniya shchitovidnoi zhelezy i beremennost'. M: MedEkspertPress 2003; 48.
Fadeev V.V. Verkhnii referensnyi uroven' TTG - dostatochno li argumentov dlya ego izmeneniya. Probl endokrinol 2008; 1: 46-50.
Fadeev V.V. Zabolevaniya shchitovidnoi zhelezy v regione legkogo iodnogo defitsita: epidemiologiya, diagnostika, lechenie. M: Vidar-M 2005; 240.
Fadeev V.V., Mel'nichenko G.A. Gipotireoz: Rukovodstvo dlya vrachei. M 2004; 214.
Tsurkan S.V., Vdovenko S.A. Dogestatsionnaya podgotovka supruzheskoi pary kak obshchepopulyatsionnaya programma pervichnoi profilaktiki prenatal'noi patologii v Samarskoi oblasti. Ros vestn akush-gin 2009; 9: 5: 9-14.
Abalovich M., Alcaraz G., Kleiman-Rubinsztein J., Pavlove M.M., Cornelio C., Levalle O., Gutierrez S. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid 2010; 20: 10: 1175-1178.
Abbassi-Ghanavati M., Casey B.M., Spong C.Y., McIntire D.D., Halvorson L.M., Cunningham F.G. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol 2010; 116: 2 Pt 1: 381-386.
Alexander E.K., Marquesee E., Lawrence J., Jarolim P., Fischer G.A., Larsen P.R. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Eng J Med 2004; 351: 241.
American College of Obstetricians and Gynecologists: Thyroid disease in pregnancy. Practice Bulletin 2002; 37: 10.
American College of Obstetricians and Gynecologists: Subclinical hypothyroidism in pregnancy. Committee Opinion 2007; 381: 2.
Amino N., Izumi Y., Hidaka Y., Takeoka K., Nakata Y., Tat-sumi K.I., Nagata A., Takano T. No increase of blocking type antithyrotropin receptor antibodies during pregnancy in patients with Graves'disease. J Clin Endocrinol Metabol 2003; 88: 12: 5871.
Azizi F., Smyth P. Breastfeeding and maternal and infant iodine nutrition. Clin Endocrinol (Oxf) 2009; 70: 803-809.
Becker D.V., Braverman L.E., Delange F., Dunn J.T., Franklyn J.A., Hollowell J.G., Lamm S.H., Mitchell M.L., Pearce E., Robbins J., Rovet J.F. Iodine supplementation for pregnancy and lactation - United States and Canada: Recommendations of the American Thyroid Association. Thyroid 2006; 16: 949.
Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metabol 2007; 3: 3: 249.
Bonet-Manso M.P., Atienzar-Martinez M.B., Fuentes-Gomez M.I., Plaza-Vicente C. Iodine levels and intake in a population of healthy pregnant women. Enferm Clin 2007; 17: 6: 293-299.
Brent G.A. Graves'disease. N Eng J Med 2008; 358: 2594.
Casey B.M., Leveno K.J. Thyroid disease in pregnancy. Obstet Gynecol 2006; 108: 1283.
Casey B.M., Dashe J.S., Spong C.Y., McIntire D.D., Leveno K.J., Cunningham F.G. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol 2007; 109: 1129-1135.
Casey B.M., Dashe J.S., Wells C.E., McIntire D.D., Byrd W., Leveno K.J., Cunningham F.G. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005; 105: 239-245.
Cleary-Goldman J., Malone F.D., Lambert-Messerlian G., Sullivan L., Canick J., Porter T.F., Luthy D., Gross S., Bianchi D.W., D'Alton M.E. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 2008; 112: 85-92.
Costeira M.J., Oliveira P., Santos N.C., Ares S., Saenz-Rico B., Morreale de Escobar G., Palha J.A. Psychomotor development of children from an iodine-deficient region. J Pediatr 2011; 159: 447-453.
Glinoer D. The importance of iodine nutrition during pregnancy. Publ Health Nutr 2007; 10: 1542-1546.
Glinoer D., Spencer C.A. Serum TSH determinations in pregnancy: how, when and why? Nat Rev Endocrinol 2010; 6: 526-529.
Gyamfi C., Wapner R.J., D'Alton M.E. Thyroid dysfunction in pregnancy. The basic science and clinical evidence surrounding the controversy in management. Obstet Gynecol 2009; 113: 702.
Hess S.Y. The impact of common micronutrient deficiencies on iodine and thyroid metabolism: the evidence from human studies. Best Pract Res Clin Endocrinol Metabol 2010; 24: 1: 117-132.
Horacek J., Spitalnikova S., Dlabalova B., Malirova E., Vizda J., Svilias I., Cepkova J., Mc Grath C., Maly J. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010; 163: 645-650.
Lockwood C.M., Grenache D.G., Gronowski A.M. Serum human chorionic gonadotropin concentrations greater than 400,000 IU/L are invariably associated with suppressed serum thyrotropin concentrations. Thyroid 2009; 19: 863-868.
Loh J.A., Wartofsky L., Jonklaas J., Burman K.D. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid 2009; 19: 269-275.
Lucas A., Pizarro E., Granada M.L., Salinas I., Roca J., Sanmarti A. Postpartum thyroiditis: Long-term follow up. Thyroid 2005; 15: 1177.
Mannisto T., Vaarasmaki M., Pouta A., Hartikainen A.L., Ruokonen A., Surcel H.M., Bloigu A., Jarvelin M.R., Suvanto E. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metabol 2010; 95: 1084-1094.
Negro R., Schwartz A., Gismondi R., Tinelli A., Mangieri T., Stagnaro-Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metabol 2010; 95: 1699-1707.
Negro R., Schwartz A., Gismondi R., Tinelli A., Mangieri T., Stagnaro-Green A. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metabol 2010; 95: 44-48.
Pederson C.A., Johnson J.L., Silva S., Bunevicius R., Meltzer-Brody S., Hamer RM., Leserman J. Antenatal thyroid correlates of postpartum depression. Psychoneuroendocrinology 2007; 32: 3: 235-245.
Renne C., Lopez E.R., Steimle-Grauer S.A., Ziolkowski P., Pani M.A., Luther C., Holzer K., Encke A., Wahl R.A., Bechstein W.O., Usadel K.H., Hansmann M.L., Badenhoop K. Thyroid fetal male microchimerisms in mothers with thyroid disorders: Presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J Clin Endocrinol Metabol 2004; 89: 11: 5810-5814.
Rust D.W., Bianchi D.W. Microchimerism in endocrine pathology. Endocr Pathol 2009; 20: 1: 11.
Stagnaro-Green A., Chen X., Bogden J.D., Davies T.F., Scholl T.O. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 2005; 15: 4: 351-357.
Stagnaro-Green A., Schwartz A., Gismondi R., Tinelli A., Mangieri T., Negro R. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocrinol Metabol 2011; 96: 652-657.
Surks M.I., Ortiz E., Daniels G.H., Sawin C.T., Col N.F., Colin R.H., Franklyn J.A., Hershman J.M., Burman K.D., Denke M.A., Gorman C., Cooper R.S., Weismann N.G. Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 2: 228.
Triggiani V., Tafaro E., Giagulli V.A., Sabba C., Resta F., Licchelli B., Guastamacchia E. Role of iodine, selenium and other micronutrients in thyroid function and disorders. Endocrinol Metabol Immune Dis Drug Targets 2009; 9: 3: 277-294.
Velasco I., Carreira M., Santiago P., Muela J.A., Garcia-Fuentes E., Sanchez-Munoz B., Garriga M.J., Gonzalez-Fernandez M.C., Rodriguez A., Caballero F.F., Machado A., Gonzalez-Romero S., Anarte M.T., Soriguer F. Effect of iodine prophylaxis during pregnancy on neurocognitive development of children during the first two years of life. J Clin Endocrinol Metabol 2009; 94: 3234-3241.
Weetman J.P. Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 2004; 61: 405.
Williams Obstetrics 23rd Edition. Eds by F.G. Cunningham et al. McGraw-Hill 2010; 1669.
World Health Organization/International Council for the Control of the Iodine Deficiency Disorders/United Nations Children's Fund (WHO/ICCIDD/UNICEF) Assessment of the iodine deficiency disorders and monitoring their elimination. World Health Organization (Geneva) 2007; 97.
Zimmermann M.B. Iodine deficiency. Endocr Rev 2009; 30: 376-408.